CohBar Overview
- Year Founded
-
2007

- Status
-
Public
- Employees
-
10

- Share Price
-
$0.41
- (As of Monday Closing)
CohBar General Information
Description
CohBar Inc is a biotechnology company. It is engaged in the research and development of mitochondria-based therapeutics (MBTs) to treat various diseases associated with aging and metabolic dysfunction. The product portfolio of the company includes drugs such as CB4209 and CB4211, SHLP-6, SHLP-2, and new MBTs, these address a broad range of age-related diseases, including obesity, fatty liver disease, Type-2 diabetes, cancer, cardiovascular and neurodegenerative diseases. Geographically all the operations of the group functioned through the region of the United States.
Contact Information
Website
www.cohbar.comCorporate Office
- 1455 Adams Drive
- Suite 1308
- Menlo Park, CA 94025
- United States
Corporate Office
- 1455 Adams Drive
- Suite 1308
- Menlo Park, CA 94025
- United States
CohBar Stock Performance
As of 06-Jan-2025, CohBar’s stock price is $0.41. Its current market cap is $1.19M.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.41 | $0.41 | $1.19M | 4.29K |
CohBar Financials Summary
As of 30-Jun-2023, CohBar has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | (5,971) | (13,413) | 15,458 | 62,132 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (13,028) | (12,287) | (15,307) | (15,334) |
Net Income | (12,687) | (12,175) | (15,476) | (16,265) |
Total Assets | 12,506 | 16,366 | 27,296 | 21,908 |
Total Debt | 0 | 0 | 366 | 698 |
CohBar Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CohBar Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
CohBar Patents
CohBar Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230372434-A1 | Method of treating fibrosis with a combination therapy | Pending | 21-Oct-2020 | ||
EP-4135738-A2 | Method of treating coronavirus infections | Inactive | 15-Apr-2020 | ||
US-20230218710-A1 | Method of treating coronavirus infections | Pending | 15-Apr-2020 | ||
US-20240034753-A1 | Therapeutic peptides | Pending | 29-Jan-2020 | ||
US-20220395553-A1 | Cxcr4 antagonist peptides | Pending | 14-Nov-2019 | C07K14/7158 |
CohBar Signals
CohBar ESG
Risk Overview
Risk Rating
Updated October, 22, 2020
36.44 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,042
Rank
Percentile

Pharmaceuticals
Industry
of 947
Rank
Percentile

Biotechnology
Subindustry
of 427
Rank
Percentile

CohBar FAQs
-
When was CohBar founded?
CohBar was founded in 2007.
-
Where is CohBar headquartered?
CohBar is headquartered in Menlo Park, CA.
-
What is the size of CohBar?
CohBar has 10 total employees.
-
What industry is CohBar in?
CohBar’s primary industry is Biotechnology.
-
Is CohBar a private or public company?
CohBar is a Public company.
-
What is the current stock price of CohBar?
As of 06-Jan-2025 the stock price of CohBar is $0.41.
-
What is the current market cap of CohBar?
The current market capitalization of CohBar is $1.19M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »